Home > Insider Trading > Filing (0000028823-20-000058)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
28823	Diebold Nixdorf Inc	DBD	Calculating & Accounting Machines (No Electronic Computers) (3578)	340183970

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686746	Robert Olaf Heyden	C/O Diebold Nixdorf, Incorporated 5995 Mayfair Rd. North Canton OH 44720	Svp, Services	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-02-28	12,000	$7.06	211,487	No	4	P	Direct
Common Shares	Acquisiton	2020-02-28	1,000	$6.95	212,487	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Non-Qualified Stock Options	$26.60	2018-02-08	2027-02-08	49,650	49,650	Direct
Common Shares	Non-Qualified Stock Option	$18.75	2019-02-01	2028-02-01	30,278	30,278	Direct
Common Shares	Non-Qualified Stock Option	$4.08	2020-01-29	2029-01-29	47,407	47,407	Direct
Common Shares	Non-Qualified Stock Option	$11.96	2021-01-30	2030-01-31	12,614	12,614	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-02-08	49,650	49,650	Direct
2028-02-01	30,278	30,278	Direct
2029-01-29	47,407	47,407	Direct
2030-01-31	12,614	12,614	Direct

Footnotes

Original purchase price was EUR 6.40. USD amount based on the currency exchange rate for purchase date.
Number includes restricted stock units.
Original purchase price was EUR 6.30. USD amount based on the currency exchange rate for purchase date.
Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.